Literature DB >> 26559179

Fluorescent Analogue of Batimastat Enables Imaging of α-Secretase in Living Cells.

Geoffray Leriche1, Allen C Chen2, Sumin Kim2, Dennis J Selkoe2, Jerry Yang1.   

Abstract

The ADAM family of metalloproteases cleave a diverse range of transmembrane substrates, resulting in the release of their soluble ectodomains. This process of protein shedding, termed α-secretase processing, is involved in many facets of both normal and disease related cellular function. While the processing of substrates has been well documented, the regulation and trafficking of the ADAMs are less well understood. Tools that allow for the study of ADAMs under their native environment will allow for a better understanding of their regulation and activity. Here we describe the design and evaluation of a novel fluorescent analogue of a well-characterized ADAM inhibitor, Batimastat. This probe exhibited similar activity for inhibiting α-secretase processing in cells as did Batimastat. Importantly, this probe specifically labeled ADAMs fluorescently in both fixed and living cells, enabling the possibility to study the trafficking of α-secretase proteins in a dynamic environment.

Entities:  

Keywords:  ADAMs; fluorescence; live-cell imaging; probe; α-secretase

Mesh:

Substances:

Year:  2015        PMID: 26559179      PMCID: PMC4720558          DOI: 10.1021/acschemneuro.5b00283

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  30 in total

1.  Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases.

Authors:  A Anders; S Gilbert; W Garten; R Postina; F Fahrenholz
Journal:  FASEB J       Date:  2001-08       Impact factor: 5.191

2.  Synthesis of an inhibitor-tethered resin for detection of active matrix metalloproteinases involved in disease.

Authors:  Dusan Hesek; Marta Toth; Viktor Krchnak; Rafael Fridman; Shahriar Mobashery
Journal:  J Org Chem       Date:  2006-08-04       Impact factor: 4.354

3.  Synthesis and biological evaluation of orally active matrix metalloproteinase inhibitors.

Authors:  R Hirayama; M Yamamoto; T Tsukida; K Matsuo; Y Obata; F Sakamoto; S Ikeda
Journal:  Bioorg Med Chem       Date:  1997-04       Impact factor: 3.641

4.  Monoamine oxidase A inhibitor-near-infrared dye conjugate reduces prostate tumor growth.

Authors:  Jason Boyang Wu; Tzu-Ping Lin; John D Gallagher; Swati Kushal; Leland W K Chung; Haiyen E Zhau; Bogdan Z Olenyuk; Jean C Shih
Journal:  J Am Chem Soc       Date:  2015-01-27       Impact factor: 15.419

5.  Evidence that production and release of amyloid beta-protein involves the endocytic pathway.

Authors:  E H Koo; S L Squazzo
Journal:  J Biol Chem       Date:  1994-07-01       Impact factor: 5.157

6.  Leveraging kinase inhibitors to develop small molecule tools for imaging kinases by fluorescence microscopy.

Authors:  Zijuan Zhang; Nicholas Kwiatkowski; Hong Zeng; Sang Min Lim; Nathanael S Gray; Wei Zhang; Priscilla L Yang
Journal:  Mol Biosyst       Date:  2012-10

Review 7.  ADAMs family members as amyloid precursor protein alpha-secretases.

Authors:  Tobias M J Allinson; Edward T Parkin; Anthony J Turner; Nigel M Hooper
Journal:  J Neurosci Res       Date:  2003-11-01       Impact factor: 4.164

8.  Inhibition of the tumor necrosis factor-alpha-converting enzyme by its pro domain.

Authors:  Patricia E Gonzales; Ariel Solomon; Ann B Miller; M Anthony Leesnitzer; Irit Sagi; Marcos E Milla
Journal:  J Biol Chem       Date:  2004-04-20       Impact factor: 5.157

9.  A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model.

Authors:  Rolf Postina; Anja Schroeder; Ilse Dewachter; Juergen Bohl; Ulrich Schmitt; Elzbieta Kojro; Claudia Prinzen; Kristina Endres; Christoph Hiemke; Manfred Blessing; Pascaline Flamez; Antoine Dequenne; Emile Godaux; Fred van Leuven; Falk Fahrenholz
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

10.  Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor.

Authors:  J D Buxbaum; K N Liu; Y Luo; J L Slack; K L Stocking; J J Peschon; R S Johnson; B J Castner; D P Cerretti; R A Black
Journal:  J Biol Chem       Date:  1998-10-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.